Back to News & Events

DepYmed Secures $8.3M Financing

DepYmed, Inc., has announced a new financing led by Topspin Fund, L.P. and additional investors for a total of $8.3 million.

Led by former Center for Biotech BioEntrepreneur-in-Residence Andreas Grill, DepYmed is a pharmaceutical company focused on a novel phosphatase inhibition technology platform with potential therapeutic application across multiple different disease including Rett Syndrome, Wilson Disease and Breast Cancer.

Full details of the financing can be found within DepYmed’s news release.

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => 
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 4439
                    [post_author] => 3
                    [post_date] => 2024-07-30 15:29:07
                    [post_date_gmt] => 2024-07-30 19:29:07
                    [post_content] => 

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-11-19 10:50:15 [post_modified_gmt] => 2024-11-19 15:50:15 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 2907 [post_author] => 1 [post_date] => 2018-01-03 15:36:20 [post_date_gmt] => 2018-01-03 15:36:20 [post_content] => Funding Opportunity Now Available for 2018 Summer Cohort of I-Corps at NIH Did you know that the NIH and CDC offer entrepreneurship training program for small businesses? I-Corps at NIH is an experience-based program designed specifically for small biotech businesses. Through this 8-week program, you will learn how to build a strong business model that could help bring your technology to patients. The Funding Opportunity Announcement (FOA) for 2018 Summer Cohort of I-Corps at NIH is now available: PA-18-517. More information sessions will be available in early 2018 to help you better understand the program. In the meantime, please refer to the following resources to learn more about the program:
  • FOA: PA-18-517
  • Application due date: March 5, 2018, by 5 PM local time
  • Cohort schedule: June - August 2018
  • Program Information: I-Corps at NIH Program Page
  • Recordings of previous info sessions: Webinar Materials page
If you have any questions about the program, please contact NCI SBIR (ncisbir@mail.nih.gov). [post_title] => Entrepreneurship Training Program from NIH & CDC: I-Corps [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => entrepreneurship-training-program-from-nih-cdc-i-corps [to_ping] => [pinged] => [post_modified] => 2018-01-23 14:38:26 [post_modified_gmt] => 2018-01-23 14:38:26 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2907 [menu_order] => 130 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 4051 [post_author] => 4 [post_date] => 2023-03-16 14:01:07 [post_date_gmt] => 2023-03-16 14:01:07 [post_content] =>

The NIH is providing an opportunity for grantees to participate in an online entrepreneurial education platform aimed at teaching academic innovators methods to assess the commercial value of their biomedical technologies through our commercialization assistance program, Concept to Clinic: Commercializing Innovation Education (e-C3i). This program provides entrepreneurial education for investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The eC3i course is being offered to investigators with active (or in a No-Cost Extension through 9/23) NIH-funded research projects from participating Institutes and Centers.

All applications must be received no later than April 14th, 2023. Apply Today! Applications can be submitted to NIBIB-SBIR@mail.nih.gov. All NHLBI grantees are encouraged to contact us (nhlbi_sbir@mail.nih.gov) if you are interested in participating or have any questions about the application process. Learn more here.

[post_title] => NIH Grantees: Learn How to Commercialize Your Tech [post_excerpt] => The NIH is providing an opportunity for grantees to participate in an online entrepreneurial education platform aimed at teaching academic innovators methods to assess the commercial value of their biomedical technologies. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => nih-ec3i-2023 [to_ping] => [pinged] => [post_modified] => 2024-08-22 11:34:34 [post_modified_gmt] => 2024-08-22 15:34:34 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4051 [menu_order] => 5 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 3578 [post_author] => 3 [post_date] => 2020-07-13 19:27:59 [post_date_gmt] => 2020-07-13 19:27:59 [post_content] => The Life Sciences Summit™ 2020 has gone digital! Join us online on November 17th & 18th as we spotlight the next wave of emerging companies. Our online event will continue to connect emerging biotech companies and academic innovators with the capital and strategic partners needed to move new discoveries into clinical development. Save the date and visit lifesciencessummit.org for updates If your organization is interested in presenting at the Summit, or if you would like sponsor the event, please contact Diane Fabel (diane.fabel@stonybrook.edu) or call 631.632.8521.     [post_title] => Attend the Life Sciences Summit Virtually in November! [post_excerpt] => Join us online on November 17th & 18, 2020 for the The Life Sciences Summit™! [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => join-us-at-lss-virtually-in-november [to_ping] => [pinged] => [post_modified] => 2020-09-14 14:22:27 [post_modified_gmt] => 2020-09-14 14:22:27 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3578 [menu_order] => 61 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4439 [post_author] => 3 [post_date] => 2024-07-30 15:29:07 [post_date_gmt] => 2024-07-30 19:29:07 [post_content] =>

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-11-19 10:50:15 [post_modified_gmt] => 2024-11-19 15:50:15 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 261 [max_num_pages] => 87 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant

More Information

Entrepreneurship Training Program from NIH & CDC: I-Corps

More Information

NIH Grantees: Learn How to Commercialize Your Tech

More Information

Attend the Life Sciences Summit Virtually in November!

More Information